Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of Subcutaneous AIN457 in Moderate to Severe Chronic Plaque Psoriasis
jRCT2080221181Phase 2
- Sponsor
- Novartis
- Start
- Aug 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of secukinumab in psoriasis, sponsored by Novartis.
02
Drugs
secukinumab
03
Conditions
psoriasis
Beyond the preview
Go deeper on jRCT2080221181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221181.